BioSpace News Archive

Blink Health, the app that lets people get their prescription medication at much lower prices, announces it has added three former Amazon, Facebook and Microsoft leaders in senior executive roles. Bharath Chinamanthur, Christopher Plambeck and Madan Nagaldinne join in senior leadership positions at the company.

Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, released a shareholder update letter from its Chairman and CEO, Dr. Ascher Shmulewitz.

Capital Raised Alongside Expansion of Corporate and Scientific Advisory Boards

According to Coherent Market Insights, the global surgical lasers market was valued at US$ 1.4 billion in 2017, and is projected to exhibit a CAGR of 5.4% over the forecast period.

Abiomed, Inc. announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at two upcoming conferences

Pillo Health, a Boston-based technology company improving longevity and quality of life for patients managing their health at home, today announced that is has secured $11 million in funding from leading venture investors to complete its Series-A round.

BlueWillow Biologics® today announced the issuance of U.S. patent number 10,138,279 covering an intranasal NanoVax® anthrax vaccine

The American Academy of Pediatric Dentistry (AAPD), the leading authority on children’s oral health, inducted the new president and other officers and trustees for the new AAPD board of trustees in Chicago, Ill., on May 26, 2019.

Mallinckrodt plc, a global specialty biopharmaceutical company, is reporting data1 from the open-label part of the Phase 4, multicenter study assessing the efficacy and safety of Acthar® Gel in patients with persistently active rheumatoid arthritis who were previously treated with disease-modifying anti-rheumatic drugs and corticosteroids.

Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is pleased to announce the 510 clearance of QUANTA Flash® Rheumatoid Factor IgM and QUANTA Flash RF IgA assays by the US Food and Drug Administration.